Cécile Hamon

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jan van den Berg, Louis B. Bartels, H. Heidbuchel, 2022, The Lancet.

Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study

C. Leclercq, J. Zamorano, J. Deharo, 2015, European heart journal.

Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study.

E. Donal, G. Habib, P. Réant, 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Contemporary Management of Severe Symptomatic Aortic Stenosis.

Michail I. Papafaklis, Jeroen J. Bax, J. P. Cárdenas, 2021, Journal of the American College of Cardiology.

Contemporary Management of Severe Symptomatic Aortic Stenosis.

Michail I. Papafaklis, Jeroen J. Bax, J. P. Cárdenas, 2021, Journal of the American College of Cardiology.

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

Jan van den Berg, H. Heidbuchel, S. Connolly, 2022, Lancet.